go back

Sipuleucel-T (Provenge) Autologous Cell Infusion

Delaware rates for HCPCS Q2043

Sipuleucel-T, minimum of 50 million autologous CD54+ cells activated with PAP-GM-CSF, including leukapheresis and all other preparatory procedures, per infusion

Rates data updated July 2026.

Facilitymedian $50,119 · 10th–90th $50,119$50,1190%50%100%$50,119Professionalmedian $56,234 · 10th–90th $56,234$60,2560%50%90th$56,234$50.0K$100.0K$200.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Professional
Modifier
Global
Typical Low
$56,234.13
Median
$56,234.13
Typical High
$57,543.99
Cigna
Setting
Facility
Modifier
Global
Typical Low
$50,118.72
Median
$50,118.72
Typical High
$50,118.72
Cigna
Setting
Professional
Modifier
Global
Typical Low
$56,234.13
Median
$56,234.13
Typical High
$56,234.13
United
Setting
Professional
Modifier
Global
Typical Low
$52,480.75
Median
$57,543.99
Typical High
$63,095.73